Holen Sie sich die Stockscreener-App
328.95
0.30%
-0.98
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$329.93
Offen:
$327.09
24-Stunden-Volumen:
639.00K
Relative Volume:
1.05
Marktkapitalisierung:
$26.68B
Einnahmen:
$14.14B
Nettoeinkommen (Verlust:
$942.70M
KGV:
29.15
EPS:
11.2856
Netto-Cashflow:
$1.38B
1W Leistung:
+3.46%
1M Leistung:
+8.21%
6M Leistung:
+24.17%
1J Leistung:
+15.83%
1-Tages-Spanne:
$326.83
$331.56
1-Wochen-Bereich:
$314.69
$331.71
52-Wochen-Spanne:
$244.52
$341.80
Labcorp Holdings Inc Stock (LH) Company Profile
Firmenname
Labcorp Holdings Inc
Sektor
Branche
Telefon
(336) 229-1127
Adresse
358 S MAIN ST, BURLINGTON, NC
Compare LH vs TMO, DHR, NTRA, A, IQV
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
LH
Labcorp Holdings Inc
|
328.95 | 26.68B | 14.14B | 942.70M | 1.38B | 11.29 |
TMO
Thermo Fisher Scientific Inc
|
673.82 | 249.14B | 45.20B | 6.87B | 6.75B | 18.19 |
DHR
Danaher Corp
|
230.50 | 162.04B | 24.78B | 3.68B | 5.29B | 5.1743 |
NTRA
Natera Inc
|
403.95 | 58.23B | 2.50B | -226.32M | 71.51M | -1.6412 |
A
Agilent Technologies Inc
|
173.07 | 48.79B | 7.23B | 1.41B | 1.09B | 4.979 |
IQV
Iqvia Holdings Inc
|
279.36 | 45.98B | 16.63B | 1.39B | 2.12B | 8.0674 |
Labcorp Holdings Inc Stock (LH) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-07-10 | Herabstufung | HSBC Securities | Buy → Hold |
| 2025-04-02 | Eingeleitet | Redburn Atlantic | Buy |
| 2025-03-04 | Hochstufung | Citigroup | Neutral → Buy |
| 2025-01-07 | Hochstufung | Evercore ISI | In-line → Outperform |
| 2024-12-10 | Fortgesetzt | Jefferies | Buy |
| 2024-10-30 | Hochstufung | HSBC Securities | Hold → Buy |
| 2024-10-01 | Eingeleitet | Piper Sandler | Neutral |
| 2024-03-25 | Hochstufung | Argus | Hold → Buy |
| 2024-02-26 | Eingeleitet | Leerink Partners | Outperform |
| 2024-02-09 | Eingeleitet | Evercore ISI | In-line |
| 2024-01-03 | Eingeleitet | Barclays | Equal Weight |
| 2023-09-06 | Eingeleitet | HSBC Securities | Hold |
| 2022-12-12 | Herabstufung | Citigroup | Buy → Neutral |
| 2022-09-19 | Herabstufung | Argus | Buy → Hold |
| 2022-08-22 | Fortgesetzt | Morgan Stanley | Overweight |
| 2022-01-28 | Herabstufung | Deutsche Bank | Buy → Hold |
| 2021-01-11 | Hochstufung | Argus | Hold → Buy |
| 2021-01-11 | Herabstufung | Wolfe Research | Peer Perform → Underperform |
| 2021-01-08 | Herabstufung | Wolfe Research | Outperform → Peer Perform |
| 2020-07-14 | Hochstufung | BofA Securities | Neutral → Buy |
| 2020-07-13 | Hochstufung | Wolfe Research | Peer Perform → Outperform |
| 2020-06-02 | Fortgesetzt | Deutsche Bank | Buy |
| 2020-05-15 | Hochstufung | Mizuho | Neutral → Buy |
| 2020-04-29 | Herabstufung | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2020-04-27 | Hochstufung | Citigroup | Neutral → Buy |
| 2020-04-27 | Hochstufung | Wolfe Research | Underperform → Peer Perform |
| 2020-01-08 | Eingeleitet | Wells Fargo | Overweight |
| 2019-07-16 | Hochstufung | BofA/Merrill | Underperform → Neutral |
| 2019-06-21 | Hochstufung | Deutsche Bank | Hold → Buy |
| 2019-04-02 | Hochstufung | Jefferies | Hold → Buy |
| 2019-01-17 | Eingeleitet | UBS | Buy |
| 2019-01-03 | Herabstufung | BofA/Merrill | Neutral → Underperform |
| 2018-12-03 | Herabstufung | Craig Hallum | Buy → Hold |
| 2018-10-30 | Herabstufung | Argus | Buy → Hold |
| 2018-10-25 | Herabstufung | Canaccord Genuity | Buy → Hold |
| 2018-10-19 | Fortgesetzt | BofA/Merrill | Buy |
| 2018-06-07 | Hochstufung | KeyBanc Capital Mkts | Sector Weight → Overweight |
| 2018-05-01 | Hochstufung | Robert W. Baird | Neutral → Outperform |
| 2018-03-23 | Eingeleitet | Argus | Buy |
Alle ansehen
Labcorp Holdings Inc Aktie (LH) Neueste Nachrichten
Labcorp stock: Labcorp declares USD 0.72 dividend for Labcorp stock - AD HOC NEWS
The FDA, Labcorp and Charles River aim to improve how medicines’ abuse risk is assessed. - Stock Titan
LH vs. DHR: Which Stock Is the Better Value Option? - Zacks Investment Research
Labcorp Holdings (LH) Declares $0.72 Quarterly Cash Dividend - GuruFocus
Natera Partners With TransCode to Advance Colorectal Cancer Trial - Zacks Investment Research
Labcorp Holdings Inc. Quarterly Dividend, Payable on December 11, 2026 - marketscreener.com
Form 8K Labcorp Holdings Inc For: 21 October By Investing.com - Investing.com Canada
Labcorp Declares $0.72 Quarterly Dividend, Payable Dec. 11 - TradingView
Labcorp Declares Quarterly Dividend - StreetInsider
Labcorp Holdings Inc. (LH) Declares $0.72 Quarterly Dividend - TradingView
Labcorp Holdings Inc. stock outperforms competitors on strong trading day - MarketWatch
Why Is Myriad Genetics Stock Trading Higher Today?Myriad Genetics (NASDAQ:MYGN) - Benzinga
Labcorp acquisition spree continues - BioWorld News
Labcorp Holdings Inc. $LH Stake Lessened by Assenagon Asset Management S.A. - MarketBeat
Weekly Recap: 2026 outlook raise and $250M acquisition revenue boost - TradingView
Labcorp Holdings Inc. $LH Shares Sold by Birch Hill Investment Advisors LLC - MarketBeat
Labcorp Holdings Inc. $LH Shares Sold by Curated Wealth Partners LLC - MarketBeat
Labcorp Holdings Inc. stock underperforms Friday when compared to competitors - MarketWatch
OPKO Health to Sell Select BioReference Assets to Labcorp for $722M - Zacks Investment Research
OPKO Health to Sell Select BioReference Assets to Labcorp for $722M - TradingView
PACS Group, Inc. (PACS) Surges 6.2%: Is This an Indication of Further Gains? - Zacks Investment Research
Labcorp (LH) Stock Looks In Step With Its Cash Flow Outlook - Yahoo Finance
Why Is Opko Health Stock Gaining Thursday?OPKO Health (NASDAQ:OPK), Labcorp Holdings (NYSE:LH) - Benzinga
Labcorp (LH) to Acquire BioReference Health Assets in $872M Deal - GuruFocus
Labcorp to buy select assets from Opko Health unit for up to $872 million - Reuters
Labcorp to buy select assets of OPKO’s BioReference Health for up to $872M - Seeking Alpha
Labcorp Enters into Agreement with OPKO Health to Acquire Select Assets of BioReference Health - PR Newswire
Labcorp Holdings Inc.: Dividend historical data and projections - www.marketscreener.com
Labcorp Holdings Inc. (LH) stock price, news, quote and history - Yahoo Finance Singapore
Arianna Huffington's Thrive Global and Labcorp pair five health measures with habit advice - Stock Titan
Labcorp Holdings Inc. stock outperforms competitors on strong trading day - MarketWatch
Labcorp (LH): Is Its Earnings Discount Worth the Growing Investment Bill? - Yahoo Finance
Global Decentralized Clinical Trials Market Size, Trends, and Forecast, 2025-2030 | AI, Wearables, and Cloud-Based Platforms Fuel 13.7% CAGR to $18.8 Billion - GlobeNewswire Inc.
Labcorp (NYSE:LH) Stock Price Breaks Above Two Hundred Day Moving AverageShould You Sell? - MarketBeat
Labcorp Holdings Inc. (LH) Options Chain - Yahoo! Finance Canada
What to Expect From Labcorp Holdings’ Q3 2026 Earnings Report - Yahoo Finance
Here's Why Labcorp Holdings (LH) is a Strong Value Stock - Zacks Investment Research
Labcorp Holdings Inc. (N6B.DE) analyst ratings, estimates and forecasts - Yahoo Finance Australia
Labcorp Holdings Inc. (N6B.DE) insider ownership and holdings - Yahoo Finance UK
Labcorp Holdings Inc. (N6B.DE) Analyst Ratings, Estimates & Forecasts - Yahoo! Finance Canada
Labcorp Holdings Inc. stock outperforms competitors on strong trading day - MarketWatch
Labcorp Holdings Inc. stock outperforms competitors on strong trading day - MarketWatch
Labcorp Holdings Inc. (N6B.DE) Stock Price, News, Quote & History - Yahoo! Finance Canada
Labcorp Holdings Inc. (N6B.DE) Stock Forum & Discussion - Yahoo! Finance Canada
Labcorp Holdings Inc. stock outperforms competitors despite losses on the day - MarketWatch
Labcorp stock after-hours at EUR 273.00: plus 0.74 percent versus Lang & Schwarz prior close - AD HOC NEWS
Truist raises target for Labcorp stock to USD 365.00 - AD HOC NEWS
Labcorp, the company behind Labcorp stock, sets results date - AD HOC NEWS
Labcorp Holdings Inc. (NYSE:LH) Stock Has Average Price Target of $337.73 According to Brokerages - MarketBeat
DHR's Growth Backed by Strong Biotechnology Unit: Can It Maintain the Pace? - Zacks Investment Research
Finanzdaten der Labcorp Holdings Inc-Aktie (LH)
Umsatz
Nettogewinn
Free Cashflow
ENV
Labcorp Holdings Inc-Aktie (LH) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| KERRII B ANDERSON | Director |
Aug 17 '26 |
Proposed Sale |
318.13 |
3,000 |
954,390 |
0 |
| Schechter Adam H | Officer |
Aug 11 '26 |
Proposed Sale |
320.37 |
4,669 |
1,495,808 |
0 |
| Schechter Adam H | President & CEO |
Aug 11 '26 |
Sale |
320.37 |
4,669 |
1,495,808 |
102,565 |
| Summy Amy B. | EVP, Chief Marketing Officer |
Aug 04 '26 |
Sale |
306.74 |
924 |
283,428 |
6,956 |
| Summy Amy B. | Officer |
Aug 04 '26 |
Proposed Sale |
306.74 |
924 |
283,428 |
0 |
| Wilkinson Peter J | SVP, Chief Accounting Officer |
Aug 03 '26 |
Sale |
309.23 |
1,420 |
439,107 |
1,770 |
| Wilkinson Peter J | SVP, Chief Accounting Officer |
Aug 03 '26 |
Option Exercise |
209.25 |
1,338 |
279,976 |
3,108 |
| Vaughn Bryan T | EVP and President, Diagnostics |
Jul 02 '26 |
Sale |
286.19 |
234 |
66,968 |
6,746 |
| Kyle Kathryn W | EVP, Chief Legal Officer |
Jul 02 '26 |
Sale |
286.19 |
92 |
26,329 |
3,904 |
| Kyle Kathryn W | Officer |
Jul 02 '26 |
Proposed Sale |
286.19 |
92 |
26,329 |
0 |
3.77%
0.85%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):